This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
T

ASCO® 2024 Insights: "Glofitamab Monotherapy in Patients With Heavily Pretreated R/R MCL"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Tycel Phillips
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Tycel Phillips
61 views
June 25, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

2024 ASCO® Annual Meeting Insights Hub: Hematologic Oncology Videos

06:26

Post-Transplant Cyclophosphamide Based GVHD Prophylaxis in Patients …

ecancer

M. Al Malki, S. Devine

42 views

·

3 months ago
09:04

ASCO® 2024 Insights: "Importance of MRD in Newly Diagnosed Multiple …

ecancer

X. Leleu

77 views

·

4 months ago
27:49

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Insights from 2024 EHA Annual Meeting

T. Badar

704 views

·

4 months ago
View All

Recommended

16:57

ASCO® 2024 Summary: "Lymphoma Highlights"

2024 ASCO® Annual Meeting Insights Hub

B. D. Cheson

1.2K views

·

5 months ago
24:44

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

883 views

·

7 months ago
16:34

Top 5 Lymphoma Abstracts From ASH

Jennifer Amengual

613 views

·

6 months ago
17:24

ESMO 2024 Summary: Updates in the Treatment of MCL

2024 ESMO Annual Meeting Insights Hub

G. Hess

221 views

·

1 month ago
14:34

EZH2 Inhibition in FL: Overview and Analysis of the SYMPHONY-1 Trial

Northwestern Medicine Oncology and Hematology

L. Gordon

384 views

·

4 months ago
31:12

Practice-Changing Abstracts in NHL and HL From ASH 2023

UChicago Medicine

S. Smith

400 views

·

8 months ago
18:15

The Next Frontier of Targeted Therapy in Lymphoma

UChicago Medicine

K. Maddocks

234 views

·

3 months ago
18:24

Key Lymphoma Updates From ASH

Memorial Sloan Kettering Cancer Center

P. Torka

374 views

·

6 months ago
18:50

CLL and MCL: Experts Discuss the Use of Pirtobrutinib

MyCancerHaven

R. Vij, G. Shouse

236 views

·

6 months ago
15:18

Practical Updates on Advances in CLL and MCL

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

E. Chong

265 views

·

8 months ago
37:44

Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas

University of Colorado Division of Hematology

M. Kamdar

251 views

·

7 months ago
25:23

When Not to Watch and Wait: Emerging Strategies in the Treatment of …

Indy Hematology Review

M. Williams

146 views

·

6 months ago
10:27

ASCO® 2023 Insights: "Rates of CRS and ICANS From CIBMTR Data on US …

Insights from 2023 ASCO® Annual Meeting

J. DiPersio

573 views

·

1 year ago
40:21

Overview of Hematopoietic Cell Transplantation

Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

R. Salit

769 views

·

1 year ago
26:58

Update on Cellular Therapy in Lymphoma

Total Health

B. Randolph

114 views

·

8 months ago
22:38

Immune Effector Cell Therapy for Lymphoid Malignancies: What to Do a…

Indy Hematology Review

T. Phillips

151 views

·

6 months ago
04:34

ASH 2023 Summary: "Highlights and Key Takeaways in MCL"

Insights from 2023 ASH Annual Meeting

P. Jain

196 views

·

11 months ago
13:58

EHA 2024 Insights: Intrathecal Rituximab + Dex for Refractory Sanctu…

Insights from 2024 EHA Annual Meeting

M. Salamoon

120 views

·

4 months ago
18:26

UChicago Medicine Best of ASCO® 2024: HL, DLBCL, MCL

UChicago Medicine Annual Practice Updates in Hematology and Oncology

A. Rojek

79 views

·

2 months ago
16:05

SOHO 2023: What Is High Risk MCL and How Should We Treat It

SOHO 2023 Eleventh Annual Meeting

A. Kumar

194 views

·

1 year ago
AUTOPLAY